A breakthrough on the litigation front will extend exclusivity for certain of Gilead Sciences’ HIV meds by around six or seven years. 13 September 2022
Indian drugmaker Dr. Reddy’s Laboratories has launched a generic version of Bristol Myers Squibb’s cancer drug Revlimid (lenalidomide). 8 September 2022
AMPAC Fine Chemicals (AFC), an SK pharmteco company, has opened its new Complex Molecule Chemistry & Engineering Center in Rancho Cordova, California. 24 August 2022
Amneal Pharmaceuticals has announced that it has received Abbreviated New Drug Application (ANDA) approval from the US Food and Drug Administration (FDA) for fo 12 August 2022
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news
Company Spotlight
USA-based Insmed (NASDAQ CM: INSM) is a biopharmaceutical company on the development and commercialization of novel, targeted inhaled therapies for patients with serious rare diseases.